mRNA Vaccines Now Headed for Shrimp
It's the No. 1 favorite seafood in many countries, and the mRNA vaccines are now coming for it.
ViAqua Therapeutics, an Israeli-based biotechnology startup, has secured $8.25 million in funding for its oral RNA-based shrimp vaccine
The vaccine targets white spot syndrome virus (WSSV), which leads to a 15% reduction in global shrimp production each year
ViAqua plans to administer its RNA-based product via coated feed; the RNA molecul…
Keep reading with a 7-day free trial